在产后血液形成中对铜失调和铜的综合分析
Liyun Chen1, Qian Wu2, Chaohui Lin3
1The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China; The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou 310058, China; School of Basic Medical Sciences, School of Public Health, Xinxiang Medical University, Xinxiang 453003, China.
Science bulletin
|June 5, 2025
概括
饮食中的铜由Slc31a1 (也称为Ctr1) 运输,对血液干细胞发育和线粒体功能至关重要. 一种化合物,现在名为CupriActivitor1 (CuA1),可以通过作为铜离子体来改善贫血.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 铜的失调与各种健康障碍有关,包括血液形成,但精确的机制尚未完全理解.
- 造血干细胞 (HSC) 对于血液形成至关重要,它们的正确功能对整体健康至关重要.
研究的目的:
- 阐明饮食中的铜和运输体Slc31a1 (Ctr1) 在维持铜恒温和产后造血中的作用.
- 研究铜缺乏和Slc31a1缺乏对HSC分化和线粒体功能的影响.
- 在小鼠模型中评估elasklomol (更名为CupriActivitor1或CuA1) 在改善贫血和恢复线粒体功能方面的治疗潜力.
主要方法:
- 从饮食诱导的缺乏铜的小鼠和缺乏Slc31a1 (vKO) 的小鼠中获得的血液造血干细胞和原始细胞 (HSPC) 的转录组分析.
- 评估HSPCs中的线粒体活性.
- 将CupriActivitor1 (CuA1) 给vKO小鼠,以评估其对贫血和HSPC线粒体功能的影响.
主要成果:
- 通过Slc31a1摄取饮食中的铜对HSC差异化和承诺至关重要.
- 铜缺乏或Slc31a1缺乏会破坏HSPCs的分化程序,并通过影响Mtco1和Mtco2损害线粒体活动.
- CupriActivitor1 (CuA1) 缓解严重的贫血,并通过独立于cuproptosis的铜离子体作用,在vKO小鼠中部分恢复线粒体功能.
结论:
- 由Slc31a1介导的铜通过调节线粒体能量代谢,在HSC平衡中发挥关键作用.
- CupriActivitor1 (CuA1) 通过调节铜水平和线粒体功能,证明了对贫血和相关疾病的治疗潜力.
- 这些发现支持建立一个新的领域",铜学",以加深对铜的生理和病理作用的理解.
相关概念视频
Overview of Hematopoiesis
4.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.8K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K


